Relief Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 13-12-2024
- Paid Up Capital ₹ 4.00 M
as on 13-12-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.76 Cr
as on 13-12-2024
- Satisfied Charges ₹ 20.43 Cr
as on 13-12-2024
- Revenue 68.73%
(FY 2022)
- Profit 221.64%
(FY 2022)
- Ebitda 410.12%
(FY 2022)
- Net Worth 31.42%
(FY 2022)
- Total Assets 25.47%
(FY 2022)
About Relief Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹7.76 Cr. The company has closed loans amounting to ₹20.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Jain, Anuj Jain, and Atul Jain serve as directors at the Company.
- CIN/LLPIN
U24232UR2005PTC010259
- Company No.
010259
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Relief Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Jain  | Whole-Time Director | 07-Dec-2006 | Current |
| Anuj Jain | Whole-Time Director | 30-Nov-2006 | Current |
| Atul Jain | Whole-Time Director | 01-Jun-2005 | Current |
Financial Performance of Relief Biotech.
Relief Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.73% increase. The company also saw a substantial improvement in profitability, with a 221.64% increase in profit. The company's net worth Soared by an impressive increase of 31.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relief Biotech?
In 2022, Relief Biotech had a public holding of 34.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zenmark Healthcare Private LimitedActive 20 years 2 months
Gaurav Jain and Atul Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 31 May 2023 | ₹4.44 M | Open |
Indian Overseas Bank Creation Date: 12 Mar 2020 | ₹7.32 Cr | Open |
Hdfc Bank Limited Creation Date: 07 Feb 2019 | ₹6.37 Cr | Satisfied |
How Many Employees Work at Relief Biotech?
Unlock and access historical data on people associated with Relief Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relief Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relief Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
